Comparative Short-Term Efficacy of Lebrikizumab and Dupilumab in Atopic Dermatitis

Atopic dermatitis (AD) is a chronic, inflammatory skin condition that significantly impairs quality of life, often requiring systemic biologic therapy like lebrikizumab or dupilumab when topical treatments fail. While both biologics have shown efficacy in separate trials when combined with…








